GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Common Stock

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Common Stock : HK$181 Mil (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Common Stock?

Shenzhen Neptunus Interlong Bio-Technique Co's quarterly common stock increased from Sep. 2023 (HK$0 Mil) to Dec. 2023 (HK$184 Mil) but then declined from Dec. 2023 (HK$184 Mil) to Jun. 2024 (HK$181 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co's annual common stock declined from Dec. 2021 (HK$205 Mil) to Dec. 2022 (HK$187 Mil) and declined from Dec. 2022 (HK$187 Mil) to Dec. 2023 (HK$184 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co Common Stock Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Common Stock Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186.72 198.92 205.47 187.39 183.54

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 183.54 - 183.54 180.64

Shenzhen Neptunus Interlong Bio-Technique Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Common Stock
Comparable Companies
HKSE:01498 HKSE:00897 HKSE:03839 HKSE:01312 HKSE:08622 HKSE:00575 HKSE:00858 HKSE:00455 HKSE:01011 HKSE:00911 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
95 Queensway, 18th Floor, United Centre, Admiralty, Hong Kong, HKG
Website
https://www.interlong.com
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines